Gilead’s HCV Drug Sofosbuvir Picks Up Easy FDA Panel Endorsement

Antiviral Drugs Advisory Committee unanimously recommends approval in HCV genotypes 1-4 and supports use in a subgroup of patients awaiting liver transplant, but says more data are needed in transplant patients with more severe disease.